205
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis, Characterization, and Antimicrobial Evaluation of Some New 1,4-Dihydropyridine Hybrid with 1,3,4-Thiadiazole

ORCID Icon, , , &
Pages 1697-1709 | Received 17 Jan 2020, Accepted 29 Jul 2020, Published online: 17 Aug 2020
 

Abstract

A synthesis of 2,2′-((2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarbonyl)bis (hydrazin-2-yl-1-ylidene))bis(N-phenylpropanehydrazonoyl chloride) (3) and studying its examining its manufactured utilities as structure hinders for novel arrangement of bis-1,3,4-thiadiazole derivatives 6a–f, 9a,b, 11, and 12 in one stage technique with great yields by reaction with different hydrazinecarbodithioate derivatives 4a–f and 7a,b. The structure of the products was built up on various analytical and spectroscopic informations. In addition, biological assessment of the acquired compounds as antibacterial and antifungal agents was accomplished and the outcomes got investigating the high potency of some of the tested compounds compared with the employed standard bactericides and fungicides. Moreover, the minimum inhibitory concentration (MIC) of the tested compounds was determined and therefore the results obtained exploring the high efficiency of a number of the tested compounds against all the tested microorganisms.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.